Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO J
2000 May 15;1910:2270-9. doi: 10.1093/emboj/19.10.2270.
Show Gene links
Show Anatomy links
Structural basis of the Axin-adenomatous polyposis coli interaction.
Spink KE
,
Polakis P
,
Weis WI
.
???displayArticle.abstract???
Axin and the adenomatous polyposis coli (APC) tumor suppressor protein are components of the Wnt/Wingless growth factor signaling pathway. In the absence of Wnt signal, Axin and APC regulate cytoplasmic levels of the proto-oncogene beta-catenin through the formation of a large complex containing these three proteins, glycogen synthase kinase 3beta (GSK3beta) and several other proteins. Both Axin and APC are known to be critical for beta-catenin regulation, and truncations in APC that eliminate the Axin-binding site result in human cancers. A protease-resistant domain of Axin that contains the APC-binding site is a member of the regulators of G-protein signaling (RGS) superfamily. The crystal structures of this domain alone and in complex with an Axin-binding sequence from APC reveal that the Axin-APC interaction occurs at a conserved groove on a face of the protein that is distinct from the G-protein interface of classical RGS proteins. The molecular interactions observed in the Axin-APC complex provide a rationale for the evolutionary conservation seen in both proteins.
Behrens,
Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
1998, Pubmed,
Xenbase
Behrens,
Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
1998,
Pubmed
,
Xenbase
Brannon,
A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus.
1997,
Pubmed
,
Xenbase
Brünger,
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.
1992,
Pubmed
Brünger,
Crystallography & NMR system: A new software suite for macromolecular structure determination.
1998,
Pubmed
Collaborative Computational Project, Number 4,
The CCP4 suite: programs for protein crystallography.
1994,
Pubmed
Dale,
Signal transduction by the Wnt family of ligands.
1998,
Pubmed
de Alba,
Solution structure of human GAIP (Galpha interacting protein): a regulator of G protein signaling.
1999,
Pubmed
Esnouf,
An extensively modified version of MolScript that includes greatly enhanced coloring capabilities.
1997,
Pubmed
Fagotto,
Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
1999,
Pubmed
,
Xenbase
Fan,
Wnt signaling and transcriptional control of Siamois in Xenopus embryos.
1998,
Pubmed
,
Xenbase
Fukuchi,
Beta-catenin mutation in carcinoma of the uterine endometrium.
1998,
Pubmed
Ginsburg,
Autonomous and nonautonomous regulation of axis formation by antagonistic signaling via 7-span cAMP receptors and GSK3 in Dictyostelium.
1997,
Pubmed
,
Xenbase
Guan,
Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.
1991,
Pubmed
Hamada,
Identification and characterization of E-APC, a novel Drosophila homologue of the tumour suppressor APC.
1999,
Pubmed
Hart,
Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
1998,
Pubmed
,
Xenbase
He,
Identification of c-MYC as a target of the APC pathway.
1998,
Pubmed
Hsu,
Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain.
1999,
Pubmed
Ikeda,
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
1998,
Pubmed
Ilyas,
Beta-catenin mutations in cell lines established from human colorectal cancers.
1997,
Pubmed
Jones,
Improved methods for building protein models in electron density maps and the location of errors in these models.
1991,
Pubmed
Kishida,
Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
1998,
Pubmed
Mao,
Specific involvement of G proteins in regulation of serum response factor-mediated gene transcription by different receptors.
1998,
Pubmed
McCartney,
Drosophila APC2 is a cytoskeletally-associated protein that regulates wingless signaling in the embryonic epidermis.
1999,
Pubmed
Merritt,
Raster3D Version 2.0. A program for photorealistic molecular graphics.
1994,
Pubmed
Miyoshi,
Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.
1998,
Pubmed
Miyoshi,
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.
1992,
Pubmed
Morin,
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
1997,
Pubmed
Munemitsu,
Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.
1995,
Pubmed
Orford,
Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin.
1997,
Pubmed
Otwinowski,
Processing of X-ray diffraction data collected in oscillation mode.
1997,
Pubmed
Palacios,
Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
1998,
Pubmed
Polakis,
The oncogenic activation of beta-catenin.
1999,
Pubmed
Riese,
LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic.
1997,
Pubmed
Rubinfeld,
Stabilization of beta-catenin by genetic defects in melanoma cell lines.
1997,
Pubmed
Rubinfeld,
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.
1996,
Pubmed
Rubinfeld,
Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene.
1997,
Pubmed
Sakanaka,
Functional domains of axin. Importance of the C terminus as an oligomerization domain.
1999,
Pubmed
Sakanaka,
Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
1998,
Pubmed
Satoh,
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
2000,
Pubmed
Shtutman,
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
1999,
Pubmed
Smalley,
Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription.
1999,
Pubmed
Su,
Association of the APC tumor suppressor protein with catenins.
1993,
Pubmed
Tesmer,
Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis.
1997,
Pubmed
Tetsu,
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
1999,
Pubmed
van de Wetering,
Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF.
1997,
Pubmed
Willert,
Beta-catenin: a key mediator of Wnt signaling.
1998,
Pubmed
Xu,
WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene.
2000,
Pubmed
Yamamoto,
Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.
1998,
Pubmed
,
Xenbase
Yu,
A new Drosophila APC homologue associated with adhesive zones of epithelial cells.
1999,
Pubmed
Zeng,
The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation.
1997,
Pubmed
,
Xenbase
Zheng,
Divergence of RGS proteins: evidence for the existence of six mammalian RGS subfamilies.
1999,
Pubmed
Zurawel,
Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
1998,
Pubmed
